A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Anxiety
NCT04211376 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2025-06-05
Summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Conditions
- Anxiety
- Anxiety Disorders
- Anxiety Depression
Interventions
- OTHER
-
No Intervention
There is no intervention for this study
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-02
- Primary Completion
- 2030-03-31
- Completion
- 2030-07-31
Countries
- United States
Study Locations
More Related Trials
-
Pilot Study to Assess the Effect of a Postbiotic Blend on Moderate Self-reported Anxiety
NCT05562739 ·Status: COMPLETED ·Phase: NA
-
Pathogenesis of Pediatric Obsessive-compulsive Disorder: Based on the Microbiota-gut-brain Axis
NCT06754319 ·Status: ENROLLING_BY_INVITATION
-
Examining the Effects of Reduced Environmental Stimulation on Anxiety
NCT03051074 ·Status: COMPLETED ·Phase: NA
-
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders
NCT02266446 ·Status: COMPLETED ·Phase: NA
-
An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
NCT00537615 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
NCT00108836 ·Status: COMPLETED ·Phase: PHASE2
-
A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
NCT00236067 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Parturients With Anxiety
NCT04662463 ·Status: WITHDRAWN ·Phase: NA
-
Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
NCT02431845 ·Status: RECRUITING ·Phase: NA
-
Brief Anxiety Sensitivity Treatment for Obsessive Compulsive Symptoms
NCT02635178 ·Status: COMPLETED ·Phase: NA
-
Cognitive and Biological Responses in Stress
NCT05026333 ·Status: COMPLETED ·Phase: NA
-
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
NCT03683472 ·Status: COMPLETED ·Phase: NA
-
Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
NCT02467374 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
NCT04598867 ·Status: UNKNOWN ·Phase: PHASE3
-
6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
NCT00738738 ·Status: WITHDRAWN ·Phase: PHASE3
-
Experimental Medication For the Treatment of Generalized Anxiety Disorder
NCT00097708 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD)
NCT06051721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
NCT00214994 ·Status: COMPLETED ·Phase: PHASE3
-
A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
NCT00735267 ·Status: TERMINATED ·Phase: PHASE3
-
Study on the Efficacy Mechanism of Natural Psychotherapy for Neurosis
NCT05552014 ·Status: COMPLETED ·Phase: NA
-
Generalized Anxiety and Seroquel
NCT01066143 ·Status: TERMINATED ·Phase: NA
-
A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
NCT00658372 ·Status: TERMINATED ·Phase: PHASE3
-
Brief Intervention for OCD Fears
NCT02790710 ·Status: WITHDRAWN ·Phase: PHASE4
-
Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study)
NCT00947570 ·Status: COMPLETED ·Phase: NA
-
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
NCT00062517 ·Status: COMPLETED